Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies

Jakob Kristinsson,1 Jón Snaedal,2 Gudlaug Tórsdóttir,1,2 Torkell Jóhannesson11Department of Pharmacology and Toxicology, University of Iceland, Reykjavik, Iceland; 2Department of Geriatrics, Landspitali University Hospital, Reykjavik, IcelandAbstract: Ceruloplasmin (Cp) concentration and oxidative a...

Full description

Bibliographic Details
Main Authors: Kristinsson J, Snaedal J, Tórsdóttir G, Jóhannesson T
Format: Article in Journal/Newspaper
Language:English
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/dd13995211df446cbde251f2cf38d684
id ftdoajarticles:oai:doaj.org/article:dd13995211df446cbde251f2cf38d684
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:dd13995211df446cbde251f2cf38d684 2023-05-15T16:48:44+02:00 Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies Kristinsson J Snaedal J Tórsdóttir G Jóhannesson T 2012-11-01T00:00:00Z https://doaj.org/article/dd13995211df446cbde251f2cf38d684 EN eng Dove Medical Press http://www.dovepress.com/ceruloplasmin-and-iron-in-alzheimerrsquos-disease-and-parkinsonrsquos--a11423 https://doaj.org/toc/1176-6328 https://doaj.org/toc/1178-2021 1176-6328 1178-2021 https://doaj.org/article/dd13995211df446cbde251f2cf38d684 Neuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 515-521 (2012) Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 article 2012 ftdoajarticles 2022-12-31T08:00:18Z Jakob Kristinsson,1 Jón Snaedal,2 Gudlaug Tórsdóttir,1,2 Torkell Jóhannesson11Department of Pharmacology and Toxicology, University of Iceland, Reykjavik, Iceland; 2Department of Geriatrics, Landspitali University Hospital, Reykjavik, IcelandAbstract: Ceruloplasmin (Cp) concentration and oxidative activity in serum are lowered in Parkinson’s disease (PD). In most PD patients, iron increases in the substantia nigra in the midbrain. In PD, the low Cp concentration and activity in serum and the high iron amounts in the substantia nigra appears to be correlated. An hereditary background is common in PD and variations in the Cp gene that have been found in PD are associated with high iron levels in the substantia nigra. Variations in Cp synthesis and in the incorporation of copper into the Cp molecule are essential features of PD. In Alzheimer’s disease (AD), the Cp activity in serum is lowered but not the concentration, except in the advanced stages of the disease. Generally, iron is not increased in the AD brain. In the AD brain, iron accumulates in neuritic plaques and in neurofibrillary tangles. There is also increased risk of iron-mediated tissue damage, which may possibly be counteracted by Cp. At the same time, the AD brain is short in copper, which presumably results in the deficient activity of many copper enzymes in the brain, in addition to Cp. Lowered Cp activity in serum most likely stems from lessened incorporation of copper in the Cp molecule and similar incorporation defects might also apply to other copper enzymes in AD.Keywords: ceruloplasmin, iron, copper, Alzheimer´s disease, Parkinson´s disease Article in Journal/Newspaper Iceland Directory of Open Access Journals: DOAJ Articles
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Kristinsson J
Snaedal J
Tórsdóttir G
Jóhannesson T
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
topic_facet Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
description Jakob Kristinsson,1 Jón Snaedal,2 Gudlaug Tórsdóttir,1,2 Torkell Jóhannesson11Department of Pharmacology and Toxicology, University of Iceland, Reykjavik, Iceland; 2Department of Geriatrics, Landspitali University Hospital, Reykjavik, IcelandAbstract: Ceruloplasmin (Cp) concentration and oxidative activity in serum are lowered in Parkinson’s disease (PD). In most PD patients, iron increases in the substantia nigra in the midbrain. In PD, the low Cp concentration and activity in serum and the high iron amounts in the substantia nigra appears to be correlated. An hereditary background is common in PD and variations in the Cp gene that have been found in PD are associated with high iron levels in the substantia nigra. Variations in Cp synthesis and in the incorporation of copper into the Cp molecule are essential features of PD. In Alzheimer’s disease (AD), the Cp activity in serum is lowered but not the concentration, except in the advanced stages of the disease. Generally, iron is not increased in the AD brain. In the AD brain, iron accumulates in neuritic plaques and in neurofibrillary tangles. There is also increased risk of iron-mediated tissue damage, which may possibly be counteracted by Cp. At the same time, the AD brain is short in copper, which presumably results in the deficient activity of many copper enzymes in the brain, in addition to Cp. Lowered Cp activity in serum most likely stems from lessened incorporation of copper in the Cp molecule and similar incorporation defects might also apply to other copper enzymes in AD.Keywords: ceruloplasmin, iron, copper, Alzheimer´s disease, Parkinson´s disease
format Article in Journal/Newspaper
author Kristinsson J
Snaedal J
Tórsdóttir G
Jóhannesson T
author_facet Kristinsson J
Snaedal J
Tórsdóttir G
Jóhannesson T
author_sort Kristinsson J
title Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
title_short Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
title_full Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
title_fullStr Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
title_full_unstemmed Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
title_sort ceruloplasmin and iron in alzheimer’s disease and parkinson’s disease: a synopsis of recent studies
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/dd13995211df446cbde251f2cf38d684
genre Iceland
genre_facet Iceland
op_source Neuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 515-521 (2012)
op_relation http://www.dovepress.com/ceruloplasmin-and-iron-in-alzheimerrsquos-disease-and-parkinsonrsquos--a11423
https://doaj.org/toc/1176-6328
https://doaj.org/toc/1178-2021
1176-6328
1178-2021
https://doaj.org/article/dd13995211df446cbde251f2cf38d684
_version_ 1766038805215707136